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ABSTRACT
1. Barrier effect. Relevant models should include an anaerobic dominant flora that 
antagonizes minor bacterial populations such as drug resistant E. coli.
2. Anaerobes vs. aerobes. Aerobe counts are more precise and much less time consuming 
than anaerobe counts. Minor populations of drug resistant aerobes are sensitive markers of 
the ecosystem balance, and are directly relevant to the potential risk of antimicrobial 
residues.
3. MIC vs. plate counts. The determination of minimum inhibitory concentrations ( MIC ) of 
selected clones is time consuming, does not detect subdominant resistance (less than 1 %), 
and the MIC shift is difficult to test statistically. In contrast, direct counts of bacteria on drug 
supplemented media allows a rapid measure of minor resistant populations. 
4. Statistics: Most published designs do not include adequate statistical evaluation. This is 
critical for trials made in conventional humans and animals, where data are highly variable. 
5. Human trials: The lowest concentration of antibiotic tested in human volunteers (2mg 
oxytetracycline /d for 7d in 6 subjects) significantly increased the proportion of resistant fecal 
enterobacteria (P=0.05). However, the huge day-to-day and inter-individual variations of 
human floras make this evidence rather weak. 
6. Gnotobiotic mice inoculated with human flora are living isolated models in which the 
effect of any antimicrobial on the human gut flora can be tested. This in vivo model does 
include the barrier effect of dominant anaerobes. Inter-individual and day-to-day variations of 
bacterial populations are lower in those mice than in humans. 
7. Most resistant enterobacteria in the human gut of untreated people come from bacterial
contamination of raw foods. The relative contribution of residues in selecting antibiotic 
resistance seems to be low when compared to bacterial contamination. 
MICROBIAL EFFECTS OF ANTIMICROBIAL RESIDUES 
Three possible effects might be produced by residues on the gut flora: 
Direct risks 
Drug residues might lead to a specific infection by overgrowth of a known enteropathogen 
(e.g., Salmonella sp., Clostridium difficile) (Tancrede, 1989). 
Potential risks 
Drug residues could increase the number of potential pathogens (e.g., Enterobacteria,
Pseudomonas aeruginosa ) or of drug resistant bacteria. In healthy people this increase is not 
harmful, but in people at risk like immuno-compromized patients or patients in intensive care 
units, those bacteria may lead to opportunistic infections (Corpet, 1989a; Tancrède, 1989). 
Drug resistant commensal bacteria are not harmful either, but most resistant bacteria bear R-
plasmid. The increased size of the plasmid reservoir enables more plasmid transfers to 
pathogens, and could favor the addition of new genes on a pre-existing R-plasmid (Corpet, 
1986).
Subtle changes in flora 
Drug residues could induce changes in the flora that are not harmful to present knowledge. 
Examples are a significant change in the balance between commensal bacteria, whose role is 
unknown, a small shift in the drug resistance of anaerobes, or a change in some microflora 
associated characteristics. 
These 3 effects may be summarized as a decrease in the barrier effect. This barrier 
effect is also called bacterial antagonism, antagonistic effect, colonization resistance or 
competitive exclusion (Tancrède, 1989). The barrier effect means that the strict anaerobes of 
the dominant indigenous flora prevent the growth of minor aerobes, of R-plasmid carriers, 
and of bacterial invaders. As a consequence of this barrier effect: 
* Some resident bacteria of the gut flora remain at relatively low population levels, when 
compared with dominant anaerobes, or with population numbers of a single strain in the gut 
of a germfree animal. For example there are about 107 cells of E. coli per gram of stool, while 
the same strain inoculated alone in a germfree mouse would establish at the level of 1010
cells per gram of gut content (Freter et al., 1983a). 
* Multi-resistant strains, carrying R-plasmids, are generally not resident in the gut. In 
volunteers given a sterile diet, most resistant enterobacteria are cleared from the gut within a 
few days (Corpet, 1988a). 
* Bacterial invaders, including pathogens, that enter the gut are most often cleared from the 
gut (Van der Vaaij, 1989 ). Enteric infections can occur only with high infecting doses, or in 
special people as newborn or antibiotic-treated persons (Tancrède et al., 1977; Holmberg et 
al., 1984; Van der Vaaij et al., 1986). 
* This indirect effect of antimicrobial drugs through the weakening of barrier effect may 
explain why an antibiotic active against gram-positive organisms may cause a change in the 
gram-negative population (Gaines et al., 1980). 
From those considerations, is clear that any relevant model for the study of gut flora should 
include an anaerobic dominant flora, since this is probably important in providing a barrier 
effect against minor bacteria. 
QUANTITATIVE STUDIES OF THE FECAL FLORA 
To assess the effect of antimicrobial residues on the gut flora, one could evaluate the 
following parameters: the dominant anaerobes, the minor aerobes, the antibioresistance 
characteristics; the resistance of the flora to a challenge by a pathogenic strain, and indirect 
biochemical markers of bacterial activity. 
Fig. 1. Composition of the human fecal 
flora. Percentage of each genus are 
given within parenthesis. 
Anaerobes
Anaerobes are by far the dominant 
bacteria of the gut ecosystem, as 
shown on Fig. l. Several hundred species have been reported from the fecal flora, and the 
cultivable anaerobes constituting 80% of the bacteria in one human stool belong to 30 
different species (Moore and Holdeman, 1974). An ideal approach to assess the effect of an 
antimicrobial on the composition of gut flora would require the determination and 
enumeration of those anaerobes, and the determination of their resistance to antimicrobial 
drugs. However, technical problems make this approach impracticable. The flora has a 
complex composition, no good selective media for anaerobes are available, species and genus 
are not precisely defined, and most anaerobes are extremely oxygen sensitive. Therefore the 
exact determination of the composition of the flora in one fecal specimen is time consuming 
and rather imprecise. For instance, a specialized laboratory composed of 8 technicians can 
handle only one specimen per week, and moreover the coefficient of variation of data is at 
least 10% and often it is more than 100% (Moore and Holdeman, 1974; Moore et al., 1978). 
From a specific study of the Bacteroides fragilis group in 10 volunteers, Meijer-Severs and 
Van Santen (1986 ) concluded that at least a 3 to 4 log difference from the control sample is 
required to establish a significant change in anaerobes due to antibiotic treatment (i.e. a 1000 
to 10 000 fold decrease ) . A simplified technique has been proposed, using the morphology 
of the 96 dominant anaerobic clones from a fecal sample. One may question the ability of this 
simplified (and still time consuming ) technique to detect a small change in the flora 
composition, when for example the Bacteroides spp. are represented by only one or two 
clones in some volunteers (Tancrède and Barakat, 1989). Finally, results obtained with 
anaerobes are difficult to interpret, since there are usually not enough accurate data to the test 
the statistical significance of the observed changes, and we lack the background knowledge 
to tell if the observed effect is clinically relevant. 
A micromorphometric technique has been used to assess the effect of ceftriaxone on 
flora and appears promising. This is the direct digital image analysis of human fecal flora, 
followed by a principal components analysis of the data (Van der Vaaij, 1989; Meijer, 1991). 
Aerobes
Aerobes (or facultative anaerobes) represent a minor fraction of the human fecal flora, 
usually less than 1 % of the bacteria. Major aerobes are enterobacteria (principally E. coli ), 
and enterococci. Species are well characterized, and good selective media are available to 
count aerobes in fecal flora. Since the techniques are fast and inexpensive they can be used to 
count aerobes repeatedly and accurately yielding enough data for statistical analysis. 
Although aerobes are only a small part of the fecal flora, their determination could be a 
sensitive assessment of the gut ecosystem modification. As can be seen in Fig. 2 an 
antimicrobial affecting slightly the dominant anaerobes, and decreasing the number of 
Bacteroides sp. from 2 5 to 24% could permit a 2000% increase in the number of E. coli. The 
change in the Bacteroides sp. population would be undetectable, while the change in the E. 
coli population would be easy to detect. Some aerobes are potential pathogens, and could 
harbor plasmids and transposons that are directly infectious for pathogens: changes in aerobe 
counts following antimicrobial residues are hence directly related to public health problems. 
Fig. 2. Speculative effect of an 
antimicrobial on the composition of the 
human fecal flora. Per-cent changes for 
one genus are given in boxes. 
Antibioresistance
The antibioresistance characteristics of anaerobes and of aerobes can be determined in two 
ways: (1) a direct count of bacteria resistant to a given antimicrobial at a given concentration 
(breakpoint). (2) the determination of minimum inhibitory concentrations ( MIC ) of selected 
clones. The first method is fast, and permits the accurate determination of minor populations 
of resistant bacteria. However the choice of the breakpoint concentration for resistance is 
critical and must be based on previous data or pilot study. The second method, MIC, is time 
consuming, does not allow the accurate quantification of minor resistant populations (not 
enough selected clones), nor the detection of resistance when the ratio of total/resistant 
population is more than 1000. The statistical analysis of MIC shift is usually done by testing 
only the median MIC in control and treated flora. Only MIC determinations can detect a 
change far from the breakpoint (e.g., a doubling in the MIC of resistant bacteria, but with no 
change in their population number ) . 
Resistant populations of aerobes are sensitive markers of the modifications of the 
flora by antimicrobial drugs. Since bacteria resistant to the drug under study are not affected 
by the drug, their increase in number would reflect indirectly other perturbations of the 
ecosystem, either in the susceptible populations of the same species ( selection ), or in other 
bacteria (barrier effect modifications). Finally, an increase in the resistant population size, 
corresponding to an increased size of the R-plasmid reservoir, is directly related to public 
health.
Thus, the proportion of resistant enterobacteria appears to be simple and sensitive 
marker of gut flora changes under drug treatment. 
Pathogen challenge 
The barrier effect of a flora can be directly assessed by following the elimination of a known 
bacterial inoculum (Ducluzeau et al., 1970; Koopman et al., 1987). For instance, inocula 
containing 108 living cells of E. coli, Shigella flexneri, Salmonella typhimurium, Vibrio 
cholerae, Pseudomonas aeruginosa, Campylobacter jejuni, Staphylococcus aureus, 
Clostridium difficile, C. perfringens, or Candida albicans were given to mice, and the 
number of organisms surviving in the gut 15 days later was compared in control and in drug 
treated animals (Andremont et al. 1983; Pecquet et ai. 1991). This kind of study appears to be 
directly relevant to public health, but the sensitivity to low antimicrobial doses is unknown. 
The technique of the oral challenge with an exogenous pathogen is easy to perform in 
experimental animals, particularly in isolators, but would be unethical in human. 
Indirect biochemical markers 
A number of biochemical markers of the activity of the flora have been proposed, including 
the measure of beta-glucuronidase, 7-alpha-dehydroxylation of bile acids, conversion of 
cholesterol to coprostanol, mucin breakdown, short chain fatty acid production and 
degradation of beta-aspartylglycine (Midtvedt, 1986). Though they can be measured 
accurately, biochemical measurements are at best only indirectly related to the barrier effect, 
observed changes cannot be interpreted in terms of public health. 
EXPERIMENTAL METHODS 
Methods used to assess the effects of antimicrobial residues on gut flora include: testing in
vitro the effect of antimicrobial on pure strains, and administration of antimicrobial agents in
vivo to conventional animals, to human volunteers or to gnotobiotic mice. 
Tests in vitro 
* Lorian and de-Frietas (1979) measured the minimum antibiotic concentrations of 
antimicrobial drugs on pure strains, estimated by altered morphology or decreased growth 
rate. They showed that most antimicrobial drugs remain active at concentrations 10 times 
lower than the MIC. 
* Brady et al. (1988 ) made daily sequential inoculations of flasks containing antimicrobial 
with a pure bacterial strain. They showed that 0.1 µg tetracycline/ml "selected" a phenotype 
of increased resistance to most antibiotics, while 1 mg/ml of other antibiotics had no effect. 
The test does not seem to be relevant since the assessment of resistance is not genotypic, and 
the selection among a pure strain differs greatly from the selection conditions in an 
ecosystem. 
* Brady and Katz (1988 ) measured the mating between E. coli clones in a flask containing 
an antimicrobial for 18 h and determined the percent transfer rate. They observed almost no 
effect of low antimicrobial concentrations, except lµg tylosin/ml (shift of transfer rate from 
57 to 80%). However, since the transfer rates in vivo are between 10-14 and 10-16, one may 
question the relevance of their observation to the in vivo situation (Corpet, 1986). 
* Lebek and Egger (1983 ) studied the effect of antimicrobial drugs in an 8 h continuous flow 
culture of 3 E. coli strains, one of which carried an R-plasmid. In this chemostat, 
concentrations around one tenth of the MIC of tetracycline, chloramphenicol, and gentamicin 
were sufficient to favor the R-plasmid bearing E. coli. The experimental system mimics in 
some ways the digestive transit, and a kind of simplified barrier effect is obtained from the 
competition between E. coli strains. This model however lacks the ecological conditions in
vivo (antimicrobial metabolism, anaerobiosis, substrate limitation, growth rate), and was later 
invalidated in vivo, by testing the same strains in the gut of gnotobiotic mice (Corpet and 
Lumeau, 1987). 
The major drawback of those in vitro systems is the absence of the gut ecosystem, hence they 
cannot test the effect of residues on the barrier effect. This problem could theoretieally be 
overcome, by culturing the fecal flora in che-mostat (Miller and Wolin,1981; Freter et al., 
1983b; Corpet, 1989b). but this approach seems no simpler than the model using germfree 
mice contaminated with human fecal flora. 
Tests in vivo in conventional animals 
Antimicrobial have been tested at residue concentrations in conventional rodents, and in 
beagle dogs. A number of studies were also carried out in farm animals given growth 
promoting antimicrobials, at levels ranging from 5 to 50 ppm of the diet. 
* Conventional rodents are considered unacceptable because their gut flora is very different 
from the human one, particularly since the number of E. coli is very low in mice and rats. 
Attempts were made to provide E. coli cells continuously in the drinking water of rats, or to 
expose the rats to an environment highly contaminated with E. coli. These rodent models 
proved to be unsatisfactory for determining the no-effect level of an antimicrobial on the gut 
flora (Rollins et al., 1975). 
* The feeding of certain antimicrobial as feed additives to chickens, pigs or calves result in a 
population of resistant fecal E. coli. However the baseline incidence of resistant bacteria is 
high in farm animals, even after a 10 years without antibiotic use (Langlois et al., 1986). 
Therapeutic treatments or inter-group cross contaminations are difficult to avoid in farm 
animals studies (Linton et al., 1975). Moreover, natural changes in bacterial populations in 
the gut of chicken and pig interfere with any possible drug effect (Linton et al., 1985) 
* Rollins et al. (1975), and Gaines et al. (1978, 1980) fed groups of 5-7 beagle dogs for 35-57 
d with residue doses of oxytetracycline, dihydrostreptomycin, penicillin or virginiamycin. 
Total and resistant coliforms were counted in 5 to 10 samples from each animal, and 
compared to levels in control untreated dogs. In these well designed experiments, the 
baseline level of resistance was low and contamination was avoided by housing groups in 
separate buildings. However the inter-animal and day-to-day variability of the flora was high 
(e.g., standard deviation > mean, Gaines et al., 1980 ), leading to a low ability to detect an 
effect. Dogs, like other animals, harbor some bacteria resembling those in humans, but when 
detailed analyses are done it is evident that most of the bacterial species in the different 
animals are not the same as those in humans (Moore et al., 1978). Moreover, the drug 
metabolism is not the same in dogs and humans. However, this model seems the best 
acceptable one amongst conventional animal models, to test in vivo the effect of drug 
residues on a complex flora. 
Human volunteer trials 
* Nord et al. (1985, and 1993 elsewhere in this issue of Vet. Microbiol.) gave per os
therapeutic doses of a number of antimicrobial drugs to groups of 10 patients for 7 d. 
According to their data the drugs that are fully absorbed from the gut, and that cannot be 
detected in the stools, do not change any measured parameter of the fecal flora (including 
anaerobe counts, and antibioresistant bacteria) . Provided the methods are sensitive enough 
(detection threshold and statistical power), it is reasonable to postulate that residues of the 
drugs that produced no detectable effect at therapeutic doses cannot affect the gut flora. 
* Goldberg et al. (1961), and Knothe (1963 ) gave daily doses of oxytetracycline to 25-50 
volunteers, for 2-6 months. They did observed a sporadic increase of resistant enterobacteria 
in volunteers given 10 mg per day (resistance increase in 30% of the subjects, P < 0.01; 
Goldberg et al., 1961) . The no-effect level was not determined, and sampling was not 
frequent enough to detect a small change in a highly fluctuant parameter. 
* In volunteers given residue doses of ampicillin (Corpet, 1987), or oxytetracycline 
(Tancrede and Barakat, 1989), no firm conclusion could be drawn due to of a lack of design 
power. Two mg of oxytetracycline per day produced no detectable effect on the gross 
composition of the 96 dominant anaerobes, and no apparent shift in the MIC of 6x96 clones 
of anaerobes (no statistics were given). However, the percentage of resistant enterobacteria 
increased (P<0.01) in 2 volunteers out of 5 given ampicillin (1.5 mg/d for 21 d. 17 data pairs 
per subject ), and in the 6 others given oxytetracycline (2 mg/d for 7 d. 1 data pair per 
subject) (P=0.05, median increase 30-fold). 
Because of contamination from food, the concentration of resistant E. coli in feces varies 
enormously in humans (Corpet, 1987, 1988a). Thus a possible effect of antimicrobial drugs 
could be hidden by the natural fluctuations in resistant populations of fecal bacteria. A 
relevant trial in human would require a high number of volunteers and a long monitoring 
period. Power-based assessments of sample size are not easy to do since data are not 
distributed normally (Mann et al., 1991) . However, a posteriori calculations show that 14 
and 33 volunteers respectively would have been necessary to reach a P= 0.01 significance in 
the trials of Tancrède and Barakat (1989), and Corpet (1987) (Corpet, 1988c, p.43). 
Advantages of human trials are obvious, since no inter-species extrapolation has to be 
made. Major drawbacks are the difficulty of testing a drug not cleared for use in human, and 
the requirement to use high number of volunteers and to monitor each one for a long time, to 
overcome the variability in the fecal resistant populations. 
Gnotobiotic mice 
Gnotobiotic mice are living isolated models where the effect of antibiotics can be studied in 
the absence of contamination (Corpet, 1980; Corpet, 1984; Corpet, 1988b). 
* The minimum antibiotic levels for selecting a resistance plasmid was determined in dixenic 
mice, i.e. germfree mice harboring two isogenic E. coli strains, one of which was carrying an 
R-plasmid (Corpet and Lumeau, 1987). A strong correlation between antimicrobial dose and 
selection of the resistant E. coli clone was observed in 70 groups of 3 dixenic mice. 
Minimum selecting doses were in the range 1-10 mg/1 of drinking water (Corpet et al., 
1989). However, this model lacks the dominant anaerobic flora that provides the barrier 
effect in human gut. 
* The gross composition of the anaerobic flora, the barrier effect and the other major 
functions of the flora in the human gut are present in the gut of human flora associated mice 
(Raibaud et al., 1980; Hazenberg et al., 1981; Andremont et al., 1983; Ducluzeau et al., 1984; 
Mallet et al., 1987; Corpet, 1989b). The human flora associated mice have been used 
extensively to assess the in vivo effect of therapeutic doses of antimicrobial on the human gut 
flora com-position, and on the resistance to pathogen challenges (Hazenberg et al., 1982; 
Andremont et al. 1983; Pecquet et al. 1986, 1987, 1991). 
* Human flora associated mice can be used to test in vivo the effect of antimicrobial residues 
on human flora. In a typical trial, 20 germfree mice are first inoculated with a strain of B.
fragilis of human origin, to reduce the oxygen and substrate concentrations in the gut. Fecal 
samples from 4 human donors are diluted a hundred-fold anaerobically, pooled, introduced in 
the isolator and given by gavage to the 20 mice within 30 min after passing. The barrier 
effect was not fully transferred to the mice when the germfree mice were not preinoculated 
with a B. fragilis strain, or when the fecal human flora was frozen (- 85 ° C in prereduced 
50% glycerol) before its transfer to the mice (Corpet, 1991, unpublished data). A week after 
the flora transfer, mice are randomized to 4 isolators. Each group is given continuously for 
30-40 d a drinking bottle containing either pure water (negative control), or a selecting dose 
of the antimicrobial under study (positive control), or residue concentrations. Total and 
resistant enterobacteria and/or enterococci are monitored daily in the pooled mice feces, in 
order to get 15 to 20 data points per group. Numbers and proportions of resistant bacteria in 
treated groups are compared with control groups by a matched-pair non-parametric rank test. 
Data show that the flora is the same in recipient mice and human donor, and in different 
individual mice as well as different untreated groups of mice. In human flora associated mice, 
0.5 mg/1 of chlortetracycline or ampicillin was enough to increase 30-fold the resistant 
population of fecal E. coli (P<0.005) (Corpet, 1987). 
This model is easy to handle, yields clear cut data for statistical analysis, and meets 
the following prerequisites: (1) a low base-line of resistant bacteria, (2) no difference 
between the different groups before treatment, (3) no contamination during the trial, and 
hence a low day-to-day variability in resistance levels (4) a flora similar to the human flora, 
including a barrier effect and interactions in vivo. This model seems sensitive to the effect of 
low antimicrobial concentrations, possibly more than its human counterpart (Corpet, 1987). 
Potential drawbacks are the following: (1) the model flora is similar to human flora, 
but it is impossible to prove they are identical. (2) the results depend on the initial donor 
flora. The use of a pool from several donors helps to normalize the flora, but unless a 
standardized human flora is defined, the repetition of an experiment will never be certain 
(Corpet, 1988b). (3) the model does not include the variability of human flora (due to age, 
illness, drug treatment, and contaminations by new plasmids ). However, the same drawback 
exists in human trials. (4) the drug metabolism could be different in mice and human, and (5) 
the fecal drug concentrations in the mice must be assayed and related to concentration in 
human intestine. 
EFFECTS OF DIETARY CONTAMINATION ON HUMAN FLORA 
A sterile diet was given to 7 healthy volunteers for 2.5 weeks, after a control period of 3 
weeks. During both periods, total and antibiotic resistant lactose-fermenting enteric 
organisms were counted daily in their stools. A drastic drop in the fecal concentration of 
ampicillin, tetracycline and streptomycin resistant bacteria was observed during the sterile 
diet period (see Table 1) . It is concluded that, in the normal human population, most resistant 
enterobacteria in feces come from 
contaminated food (Corpet, 1988a). The day-
to-day increase in the number of resistant 
enterobacteria could be 1 000 000, due to the 
ingestion of a contaminated food (see Fig. 3). 
Fig. 3. Log No. of lactose-fermenting enteric 
organisms in the in stools of a volunteers 
given a sterile diet from days 21 to 40 
TABLE 1 
Resistant lactose-fermenting enteric bacteria in stools of volunteers eating a sterile diet 
Volunteer Diet Log no. of bacteria/g resistant to: 
  ampicillin tetracycline streptomycin 
A control 3.3 ± 1.7a 4.1 ± 1.8 4.1 ± 1.8 
 sterile 1.4b ± 0.1** 1.4 ± 0.1** 1.4 ± 0.0** 
B control 2.8 ± 1.4 4.8 ± 1.3 3.7 ± 1.6 
 sterile 1.4 ± 0.1* 1.7 ± 0.7** 1.4 ± 0.0** 
C control 4.3 ± 2.6 2.9 ± 2.5 2.8 ± 1.8 
 sterile 1.6 ± 0.6** 1.7 ± 0.8** 1.7 ± 0.9* 
D control 5.2 ± 2.0 5.7 ± 1.5 4.9 ± 1.6 
 sterile 1.8 ± 1.0** 2.3 ± 1.7** 1.8 ± 0.7** 
E control 2.3 ± 0.9 4.0 ± 1.3 3.6 ± 1.4 
 sterile 2.0 ± 0.8 2.7 ± 1.2* 3.3 ± 1.7 
F control 7.4 ± 1.0 7.5 ± 1.0 7.7 ± 0.8 
 sterile 5.0 ± 0.6** 5.3 ± 1.0** 7.5 ± 0.6 
G c control 2.7 ± 2.0 2.7 ± 1.0 4.8 ± 1.6 
 sterile 6.2 ± 2.0* 7.6 ± 0.6** 7.5 ± 0.5* 
total control 4.7 ± 1.7 5.2 ± 1.3 5.0 ± 1.4 
(except G)
)
sterile 2.3 ± 1.3++ 2.5 ± 1.4++ 2.9 ± 2.3+ 
a Mean results of 21 daily counts ( control ) or 17 counts ( sterile ) ± SD.  
b Counts below the detection limit (25 CFU /g ) were converted to 1.4.  
c To cure a urinary infection, volunteer G was given 1 g/d of pipemidic acid for 6 days between the two 
periods. Significance of the difference between the control and sterile periods in the same individual:  
**P<0.001, *P<0.01 (Mann-Whitney test, based on a mean number of 38 daily counts per volunteer).  
++P<0.001, +P<0.05 (paired Student t test, based on 6 pairs). 
CONCLUSION
The mean increase in resistance in volunteers given 2mg of oxytetracycline was 30-fold 
(Tancrède and Barakat, 1989). In mice with human flora given 0.5 mg chlortetracycline or 
ampicillin the mean increase in resistant population numbers was also 30-fold. Tentatively 
extrapolated to human, those concentrations are in the high range of residue levels possibly 
found in human food (Corpet, 1987). Thus antibiotic residues due to veterinary treatments 
might have a statistically significant effect on gut flora. However, the relative contribution of 
selecting residues seems low when compared with bacterial contamination. 
In our opinion and according to current knowledge, antimicrobial residues are not 
likely to have a meaningful effect on general public health. 
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